Genor Biopharma to Acquire EOC Pharma Group in a Merger Deal, Eyeing Commercialization Synergies
Genor Biopharma Holdings Limited (HKG: 6998) has announced a definitive merger agreement with EOC Pharma...
EOC Pharma
EOC Pharma’s Entinostat Secures Chinese Approval for Breast Cancer Treatment
US-China biotech firm EOC Pharma has received market approval from China’s National Medical Products Administration...
China’s NMPA Accepts EOC Pharma Group’s Filing for Vascepa (Icosapent Ethyl) for Review
The China-based EOC Pharma Group has achieved a significant milestone with the National Medical Products...
EOC Pharma Group and Nanopeptide Biotechnology Forge Partnership for siRNA Drug Development
China-based EOC Pharma Group has announced a strategic partnership with fellow country siRNA firm, Nanopeptide...
EOC Pharma’s Lusutrombopag Receives NMPA Approval for Chronic Liver Disease Treatment
China-based EOC Pharma Group has announced that its drug, lusutrombopag, has received marketing approval from...
EOC Pharma Group Partners with China National Accord Medicines for Distribution Rights
China-based EOC Pharma Group has announced a strategic partnership with compatriot firm China National Accord...
EOC Pharma’s CDK7 Inhibitor EOC237 Accepted for CDE Review
EOC Pharma, a biotech operating out of the US and China, has announced that a...
EOC Pharma’s Entinostat NDA Accepted by China’s NMPA for Breast Cancer
EOC Pharma, a biotech company operating in the US and China, has announced that its...